Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients.
Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, Ravits JM, Miller TM, Maragakis NJ, Hales CM, Glass JD, Gross S, Mitsumoto H, Manfredi G.
Konrad C, et al.
Mol Neurodegener. 2017 Oct 24;12(1):76. doi: 10.1186/s13024-017-0217-5.
Mol Neurodegener. 2017.
PMID: 29065921
Free PMC article.